Merck to Invest $70M Into New Biopharma R&D Facility

Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the United States and Canada, announced a $70 million investment to expand its research and development (R&D) facility in Billerica, Mass. The new building will span 145,000 sq. ft., offering new laboratory and collaborative working space to accommodate approximately 400 new and current R&D employees focused on advancing science in oncology, immuno-oncology and immunology....

from RSSMix.com Mix ID 8246474 https://ift.tt/2T8oaNa
via Inchiriere buldozere - Tuscher & Milas Company

Comentarii

Postări populare de pe acest blog

Ground is Broken on New Fisher Hill Elementary School in Orange, Mass.

Metso Outotec Launches Concorde Cell Flotation Technology for Fine, Ultra-Fine Particle Recovery

VIDEO: Bobcat Company Announces New Partnership With National Disaster Search Dog Foundation